HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition

HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition

Huachen Song, Xiaonan Tang, Xiang Li, Yufei Wang, Anjun Deng, Wenjie Wang, Haijing Zhang, Hailin Qin, LianQiu Wu State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing...

Full description

Bibliographic Details
Main Authors: Song H, Tang X, Li X, Wang Y, Deng A, Wang W, Zhang H, Qin H, Wu LQ
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Drug Design, Development and Therapy
Subjects:
inflammatory bowel disease
colitis-associated cancer
emt
Online Access:https://www.dovepress.com/hlj2-effectively-ameliorates-colitis-associated-cancer-via-inhibition--peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/hlj2-effectively-ameliorates-colitis-associated-cancer-via-inhibition--peer-reviewed-article-DDDT

Similar Items